journal article·2025-01-17

Bioinspired β-Cyclodextrin-Derived Carbon Dots with Emissive and Photothermal Properties as Nanocarriers for Bioactive Agents

Grazia Maria Letizia Consoli, Ludovica Maugeri, Giuseppe Forte, Dafne Bongiorno, Emanuele Nicitra, Danilo Aleo, Fabiola Spitaleri, Loredana Ferreri, Gianpiero Buscarino, Tiziana Campagna, Nicolò Musso, Salvatore Petralia

ACS Applied Nano Materials· Volume 8· Issue 2
Publisher page

Abstract

Carbon-based nanostructures are attracting significant interest due to their excellent optical properties, low toxicity, and intriguing applications. Currently, the development of multifunctional carbon-based nanostructures that integrate supramolecular systems is a challenging topic in the advancement of biomedical applications. Here, we report an unprecedented example of carbon nanodots (Cdots) prepared via a one-pot thermal method by heating 2-hydroxypropyl-β-cyclodextrin (HP-βCD) at a mild temperature of 190 °C. The nanostructured Cdots-HPβCD exhibited green luminescence (ϕ PL = 0.02), good photothermal conversion efficiency (η = 33%), and a strong bioactive agent loading capability. The Cdots-HPβCD nanostructures were characterized by using spectroscopic techniques and atomic force microscopy. The formation of Cdots-HPβCD/Iodine adducts, iodine release, and antimicrobial effect against Staphylococcus aureus and Klebsiella pneumoniae strains were demonstrated. The geometries and energy interactions of the Cdots-HPβCD/Iodine inclusion complex were investigated through molecular modeling simulations. The versatility of the Cdots-HPβCD as a drug nanocontainer was tested by entrapping other bioactive molecules such as curcumin, ciprofloxacin, and carvacrol. Finally, the low cytotoxicity of the Cdots-HPβCD nanocarrier was confirmed by MTT analysis on the Caco2 cell line, and the interaction with cancer HeLa cell surface was demonstrated by evaluation of the cellular Z potential. The binding of the nanoconstruct to albumin was investigated with steady-state fluorescence. The biofriendly Cdots-HPβCD nanoconstruct by combining the optical properties of the carbon dot core and the drug loading capability of the cyclodextrin shell appears to be a promising candidate for multimodal therapy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Carbon and Quantum Dots Applications · Nanocluster Synthesis and Applications · Luminescence and Fluorescent Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

CNR-Institute of Biomolecular Chemistry, Via Paolo Gaifami 18, Catania 95126, Italy

CIB-Interuniversity Consortium for Biotechnologies U.O. of Catania, Via Flavia, 23/1, Trieste 34148, Italy

Department of Drug and Health Sciences, University of Catania, Via Santa Sofia 64, Catania 95125, Italy

Department of Biomedicals and Biotechnologies Sciences, University of Catania, Via S. Sofia 97, Catania 95125, Italy

MEDIVIS S.R.L., Via Carnazza, 34/C, Tremestieri Etneo CT, Catania 95030, Italy

Department of Physics and Chemistry, University of Palermo, Via Archirafi 36, Palermo 90123, Italy

CNR-Institute of Crystallography, Via Paolo Gaifami 18, Catania 95126, Italy

NANOMED, Research Centre for Nanomedicine and Pharmaceutical Nanotechnology, Via Santa Sofia 64, Catania 95125, Italy

Funding

European Commission · Ministero dell'Universit? e della Ricerca

References (61)

Show source-provided references
1. 10.1021/acsabm.1c0121510.1021/acsabm.1c01215 ↗
2. 10.1002/smll.20230377310.1002/smll.202303773 ↗
3. 10.1039/D3TB01329D10.1039/D3TB01329D ↗
4. 10.1039/C9NA00794F10.1039/C9NA00794F ↗
5. 10.1002/adhm.20230369210.1002/adhm.202303692 ↗
6. 10.1039/D3TB01863F10.1039/D3TB01863F ↗
7. 10.1007/s42823-022-00359-110.1007/s42823-022-00359-1 ↗
8. 10.1002/advs.20220762110.1002/advs.202207621 ↗
9. 10.1016/j.trechm.2021.09.00310.1016/j.trechm.2021.09.003 ↗
10. 10.1021/acs.accounts.2c0057010.1021/acs.accounts.2c00570 ↗
11. 10.1016/j.bios.2023.11518710.1016/j.bios.2023.115187 ↗
12. 10.1021/acsami.1c1878610.1021/acsami.1c18786 ↗
13. 10.1002/adfm.20221385610.1002/adfm.202213856 ↗
14. 10.1002/smll.20220704810.1002/smll.202207048 ↗
15. 10.1016/j.microc.2024.11053610.1016/j.microc.2024.110536 ↗
16. 10.1016/j.cclet.2023.10868910.1016/j.cclet.2023.108689 ↗
17. 10.1039/D3NA00469D10.1039/D3NA00469D ↗
18. 10.1039/D1CC06530K10.1039/D1CC06530K ↗
19. 10.1021/acsami.2c2250010.1021/acsami.2c22500 ↗
20. Jackson C. · Pharmaceutics · 2024 · 16 · 22
21. 10.1016/j.carbpol.2022.12027510.1016/j.carbpol.2022.120275 ↗
22. 10.1016/j.carbpol.2023.12169810.1016/j.carbpol.2023.121698 ↗
23. 10.1016/j.aca.2024.34287810.1016/j.aca.2024.342878 ↗
24. 10.1016/j.aca.2024.34294810.1016/j.aca.2024.342948 ↗
25. 10.1016/j.bios.2017.06.05610.1016/j.bios.2017.06.056 ↗
26. 10.1002/cnma.20180052810.1002/cnma.201800528 ↗
27. 10.1021/acsomega.3c0087310.1021/acsomega.3c00873 ↗
28. 10.1039/C4RA11491D10.1039/C4RA11491D ↗
29. 10.1039/D2RA05089G10.1039/D2RA05089G ↗
30. 10.1002/slct.20190368010.1002/slct.201903680 ↗
31. 10.1016/j.fct.2005.03.00710.1016/j.fct.2005.03.007 ↗
32. 10.1016/j.foodhyd.2023.10962210.1016/j.foodhyd.2023.109622 ↗
33. 10.1208/s12249-018-1115-z10.1208/s12249-018-1115-z ↗
34. 10.1016/j.cyto.2023.15614410.1016/j.cyto.2023.156144 ↗
35. 10.1515/chem-2022-031910.1515/chem-2022-0319 ↗
36. 10.2147/IDR.S24962810.2147/IDR.S249628 ↗
37. 10.3390/biom1303047410.3390/biom13030474 ↗
38. 10.1063/1.44811810.1063/1.448118 ↗
39. 10.1002/prot.34004010610.1002/prot.340040106 ↗
40. 10.1002/jcc.2007810.1002/jcc.20078 ↗
41. 10.1002/jcc.2049510.1002/jcc.20495 ↗
42. 10.1063/1.338234410.1063/1.3382344 ↗
43. 10.1063/1.44879910.1063/1.448799 ↗
44. 10.1038/s41598-017-18338-210.1038/s41598-017-18338-2 ↗
45. 10.1016/j.matt.2021.10.01610.1016/j.matt.2021.10.016 ↗
46. 10.1016/j.carres.2008.10.02510.1016/j.carres.2008.10.025 ↗
47. 10.1016/j.jhin.2010.04.02610.1016/j.jhin.2010.04.026 ↗
48. 10.1021/acs.jpca.6b0098210.1021/acs.jpca.6b00982 ↗
49. 10.1021/acs.jpcb.0c0174910.1021/acs.jpcb.0c01749 ↗
50. Bhagwat, D.; Iny, O., Jr.; Pedi, F. Stabilizing Packaged Iodophor and Minimizing Leaching of Iodine Through Packaging. US 4,996,048 A, 1988.
51. 10.3390/nano1302028610.3390/nano13020286 ↗
52. 10.1016/j.cyto.2023.15614410.1016/j.cyto.2023.156144 ↗
53. 10.1002/fsn3.299410.1002/fsn3.2994 ↗
54. 10.3109/1475636090337335010.3109/14756360903373350 ↗
55. Kumar A. · Int. J. Green Pharm. · 2022 · 16 · 226
56. 10.1021/acs.molpharmaceut.6b0106610.1021/acs.molpharmaceut.6b01066 ↗
57. 10.1016/j.jddst.2022.10383410.1016/j.jddst.2022.103834 ↗
58. 10.2147/IDR.S34864310.2147/IDR.S348643 ↗
59. 10.1021/acs.molpharmaceut.1c0004610.1021/acs.molpharmaceut.1c00046 ↗
60. 10.1016/j.biomaterials.2013.07.10210.1016/j.biomaterials.2013.07.102 ↗
61. 10.1021/acs.inorgchem.7b0234110.1021/acs.inorgchem.7b02341 ↗